The best response in these studies, a CR with long-term B cell aplasia, was observed in the patient with the lowest estimated tumor burden, while a more modest PR response was noted in the patient with the greatest estimated tumor burden
The best response in these studies, a CR with long-term B cell aplasia, was observed in the patient with the lowest estimated tumor burden, while a more modest PR response was noted in the patient with the greatest estimated tumor burden.3,4 These comparisons were assisted from the measurement of CLL tumor burden, calculated as the…